EXC: Pfizer’s Chief Vaccine Officer Advised US Government On Redrafting Gain Of Function Research Policy.

Bannon's War Room Header

Pfizer’s Chief Scientific Officer for Vaccine Research and Development advised the National Science Advisory Board for Biosecurity during the group’s deliberation over redrafting government policies concerning gain of function research.

The unearthed influence of a leading Pfizer employee over the federal government’s approach to regulating gain of function research, which refers to the manipulation of pathogens to become more lethal, virulent, or transmissible to humans, follows a shocking undercover investigation from Project Veritas into the company. The group caught an employee of the pharmaceutical giant and COVID-19 vaccine maker admitting to engaging in the risky form of research to better profit off vaccines.

In light of these claims, the proximity of Pfizer’s Philip Dormitzer to the U.S. government’s effort to redraft its policies surrounding gain of function research in 2016 is curious, as he was working as the Vice President and Chief Scientific Officer for RNA and Viral Vaccines at Pfizer at the time. He held this position from September 2015 to December 2021.

In 2014, the U.S. government announced a pause on funding gain of function research while concurrently launching a deliberative process to develop a new policy aimed at better regulating the risky form of research.

The two “key voices” engaged in the debate were the National Academies, which convened two symposiums to draft and deliberate gain of function policies, and the National Science Advisory Board for Biosecurity (NSABB). The NSABB was responsible for “providing the U.S. government with recommendations on policy for the funding and conduct of gain of function research” and “serving as the official federal advisory body for providing advice on oversight of this area of dual use research.”

Put simply, the National Academies were the most influential advisor to the NSABB, which, in turn, was responsible drafting the government’s new gain of function research policy.

Among the ten members of the National Academy of Science’s Second Symposium was Dormitzer, whose Pfizer affiliations are clearly displayed on official event documents. The symposium was the final event before the NSABB finalized its draft of recommendations and took place in March 2016.

In other words, the event was highly influential over what the NSABB’s ultimate output regarding gain of function research policy would become.

Dormitzer also served as the moderator of a session titled: “Best Practices to Inform National Policy Design and Implementation: Perspectives of Key Stakeholders in the Biomedical and Public Health Communities.”

“Philip Dormitzer from the Pfizer Vaccine Research and Development Unit and a member of the Symposium Planning Committee, introduced the session as a continuation of the earlier plenary session on the U.S. policy landscape. This session would present the perspectives of several different key stakeholders, including regulatory agencies and the vaccine industry,” explained the National Academy of Science’s breakdown of the event.

Summaries of Dormitzer’s contributions consistently appear to reveal a desire for more lax regulation on gain of function research, with the symposium report noting:

“Philip Dormitzer pointed out that not all GOF research involves GOF studies of concern, and therefore not all the research needs to be overseen by any additional policy frameworks.”

“There was an exploration of the impact of over-regulating GOF research for countermeasure development. Philip Dormitzer pointed out that as one of the factors for identifying GOF studies of concern is the absence of effective countermeasures, limiting research that could provide such measures could be counter-productive. There was also consideration of the opportunity costs of not doing research, especially in justifying potential barriers to developing countermeasures,” added the summary.

He also appeared to express concern over potential “blowback” directed towards vaccines in light of discussions about gain of function research:

“Dormitzer closed with some personal observations. One was an increasing need to consider integration of the multiple biosafety and biosecurity regimens. The other was a concern about unintended consequences, for example from the “blowback” onto vaccine production from the controversies over GOF studies of concern—or GOF research more generally—in academia.”

“Dormitzer closed with some personal observations. One was an increasing need to consider integration of the multiple biosafety and biosecurity regimens. The other was a concern about unintended consequences, for example from the “blowback” onto vaccine production from the controversies over GOF studies of concern—or GOF research more generally—in academia.”

By Natalie Winters

Read Original Article on WarRoom.org

Watch The Project Veritas Video

Bannon's War Room
Bannon's War Roomhttps://warroom.org/
On Bannon's War Room, Steve Bannon brings medical experts, politicians, business leaders and more for a look at the latest news, providing insider insights.

Columns

DOGE and Musk Recover Deleted Computer Files

Elon Musk and his “Geek Squad” discovered an entire terabyte of data was deleted from government servers from the office of the “Institute of Peace”.

A Simple Question

What is a woman? Anyone with an IQ above room temperature can answer the question. Everyone, that is, except Democrats.

Democrats Tesla Takedown is a Proven Astro Turf Movement

Elon Musk and other journalistic leaders like Joe Rogan have been asking the critical question, “Who is behind the organization of these Tesla protests?”

Can Ramaphosa and Trump Come to Terms?

Whether South Africa can quell the hostility emanating from Washington, without compromising on its national priorities, is a formidable test for a country

Maddened Europe

Viable prospects for peaceful settlement of conflict between Moscow and Kyiv exist, but Europe obsesses over threat of incursion onto European territory.

News

US Immigration Services Drops 3rd Gender Option

US immigration services agency officially updated policy to recognize only two biological sexes—male and female—for all immigration-related doc and benefit requests.

Transgender Covenant School Killer Planned Attack for Years, Final Police Report Says

Transgender shooter in mass killing at Christian school in Nashville, TN was an alumnus motivated by a quest for notoriety, final police report concludes.

Supreme Court Reviews South Carolina’s Medicaid Funding Block on Planned Parenthood

U.S. Supreme Court weighed whether South Carolina can stop abortion provider Planned Parenthood from taking part in state’s Medicaid program.

Africa at Crossroads After $13 Billion US Aid Cut, Say Analysts

African countries reacted with shock when the U.S. government recently cut $13 billion in financial assistance.

Trump Admin Ordered to Restore Legal Aid for Unaccompanied Minors

Judge in CA ordered Trump admin to restore funding for nonprofits providing legal services to unaccompanied illegal immigrant children who entered US.

Val Kilmer, Star of ‘Top Gun’ and ‘Batman,’ Dies at 65

Actor Val Kilmer, best known for his roles in movies “Top Gun,” “The Doors,” and “Batman Forever,” died on April 1 at age 65, his daughter confirmed.

Princeton Says Trump Administration Has Suspended Dozens of Research Grants

Trump admin has suspended several dozen federally funded research grants to Princeton University as part of its investigation into campus anti-Semitism.

How Trump’s ‘Liberation Day’ Tariffs Are Set to Reshape Global Trade

President Donald Trump is set to announce reciprocal tariffs for all nations starting April 2, the date he has dubbed “Liberation Day.”
spot_img

Related Articles

Popular Categories

MAGA Business Central